Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J.

JCI Insight. 2019 Feb 21;4(4). pii: 124519. doi: 10.1172/jci.insight.124519. eCollection 2019 Feb 21.

2.

Patient-Centered Medical Homes in Community Oncology Practices: Changes in Spending and Care Quality Associated With the COME HOME Experience.

Waters TM, Kaplan CM, Graetz I, Price MM, Stevens LA, McAneny BL.

J Oncol Pract. 2019 Jan;15(1):e56-e64. doi: 10.1200/JOP.18.00479. Epub 2018 Dec 5.

PMID:
30523764
3.

Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.

Ishiwata-Endo H, Kato J, Tonouchi A, Chung YW, Sun J, Stevens LA, Zhu J, Aponte AM, Springer DA, San H, Takeda K, Yu ZX, Hoffmann V, Murphy E, Moss J.

JCI Insight. 2018 Nov 15;3(22). pii: 97898. doi: 10.1172/jci.insight.97898.

4.

Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases.

Stevens LA, Moss J.

Methods Mol Biol. 2018;1813:149-165. doi: 10.1007/978-1-4939-8588-3_10.

PMID:
30097866
5.

Designing An Individualized EHR Learning Plan For Providers.

Stevens LA, DiAngi YT, Schremp JD, Martorana MJ, Miller RE, Lee TC, Pageler NM.

Appl Clin Inform. 2017;8(3):924-935. doi: 10.4338/ACI-2017-04-0054. Epub 2017 Dec 20.

6.

Current noise enhancement: channel mixing and possible nonequilibrium phonon backaction in atomic-scale Au junctions.

Stevens LA, Zolotavin P, Chen R, Natelson D.

J Phys Condens Matter. 2016 Dec 14;28(49):495303. Epub 2016 Oct 17.

PMID:
27748268
7.

Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management.

Iberri DJ, Kwong BY, Stevens LA, Coutre SE, Kim J, Sabile JM, Advani RH.

Br J Haematol. 2018 Jan;180(1):164-166. doi: 10.1111/bjh.14302. Epub 2016 Aug 18. No abstract available.

PMID:
27539794
8.

A comprehensive comparison of dye-sensitized NiO photocathodes for solar energy conversion.

Wood CJ, Summers GH, Clark CA, Kaeffer N, Braeutigam M, Carbone LR, D'Amario L, Fan K, Farré Y, Narbey S, Oswald F, Stevens LA, Parmenter CD, Fay MW, La Torre A, Snape CE, Dietzek B, Dini D, Hammarström L, Pellegrin Y, Odobel F, Sun L, Artero V, Gibson EA.

Phys Chem Chem Phys. 2016 Apr 28;18(16):10727-38. doi: 10.1039/c5cp05326a.

PMID:
26734947
9.

Correction to "Ni Mg Mixed Metal Oxides for p-Type Dye-Sensitized Solar Cells".

Zannotti M, Wood CJ, Summers GH, Stevens LA, Hall MR, Snape CE, Giovannetti R, Gibson EA.

ACS Appl Mater Interfaces. 2015 Dec 16;7(49):27580. doi: 10.1021/acsami.5b11127. Epub 2015 Dec 3. No abstract available.

PMID:
26633753
10.

Ni Mg Mixed Metal Oxides for p-Type Dye-Sensitized Solar Cells.

Zannotti M, Wood CJ, Summers GH, Stevens LA, Hall MR, Snape CE, Giovannetti R, Gibson EA.

ACS Appl Mater Interfaces. 2015 Nov 11;7(44):24556-65. doi: 10.1021/acsami.5b06170. Epub 2015 Oct 27. Erratum in: ACS Appl Mater Interfaces. 2015 Dec 16;7(49):27580. Giovanetti, Rita [corrected to Giovannetti, Rita].

PMID:
26468918
11.

Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations.

Beech KE, Biddlecombe JG, van der Walle CF, Stevens LA, Rigby SP, Burley JC, Allen S.

Eur J Pharm Biopharm. 2015 Oct;96:247-54. doi: 10.1016/j.ejpb.2015.07.029. Epub 2015 Aug 4.

12.

Community Oncology Medical Homes: Physician-Driven Change to Improve Patient Care and Reduce Costs.

Waters TM, Webster JA, Stevens LA, Li T, Kaplan CM, Graetz I, McAneny BL.

J Oncol Pract. 2015 Nov;11(6):462-7. doi: 10.1200/JOP.2015.005256. Epub 2015 Jul 28.

PMID:
26220931
13.

Corrigendum: Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14608. Epub 2015 Jul 1. No abstract available.

PMID:
26131938
14.

Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Jun 4;522(7554):73-6. doi: 10.1038/nature14480. Erratum in: Nature. 2015 Sep 3;525(7567):144.

PMID:
26040890
15.

Successful physician training program for large scale EMR implementation.

Pantaleoni JL, Stevens LA, Mailes ES, Goad BA, Longhurst CA.

Appl Clin Inform. 2015 Feb 11;6(1):80-95. doi: 10.4338/ACI-2014-09-CR-0076. eCollection 2015.

16.

The value of clinical teachers for EMR implementations and conversions.

Stevens LA, Pantaleoni JL, Longhurst CA.

Appl Clin Inform. 2015 Feb 11;6(1):75-9. doi: 10.4338/ACI-2014-09-IE-0075. eCollection 2015.

17.

Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.

Stevens LA, Barbieri JT, Piszczek G, Otuonye AN, Levine RL, Zheng G, Moss J.

J Immunol. 2014 Dec 15;193(12):6144-51. doi: 10.4049/jimmunol.1303068. Epub 2014 Nov 12.

18.

Swellable, water- and acid-tolerant polymer sponges for chemoselective carbon dioxide capture.

Woodward RT, Stevens LA, Dawson R, Vijayaraghavan M, Hasell T, Silverwood IP, Ewing AV, Ratvijitvech T, Exley JD, Chong SY, Blanc F, Adams DJ, Kazarian SG, Snape CE, Drage TC, Cooper AI.

J Am Chem Soc. 2014 Jun 25;136(25):9028-35. doi: 10.1021/ja5031968. Epub 2014 Jun 11.

PMID:
24874971
19.

Immunization registries in the EMR Era.

Stevens LA, Palma JP, Pandher KK, Longhurst CA.

Online J Public Health Inform. 2013 Jul 1;5(2):211. doi: 10.5210/ojphi.v5i2.4696. Print 2013.

20.

Evidence for a common mechanism of SIRT1 regulation by allosteric activators.

Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, Pentelute BL, Schuman ER, Stevens LA, Ling AJ, Armour SM, Michan S, Zhao H, Jiang Y, Sweitzer SM, Blum CA, Disch JS, Ng PY, Howitz KT, Rolo AP, Hamuro Y, Moss J, Perni RB, Ellis JL, Vlasuk GP, Sinclair DA.

Science. 2013 Mar 8;339(6124):1216-9. doi: 10.1126/science.1231097.

21.

Instant MOFs: continuous synthesis of metal-organic frameworks by rapid solvent mixing.

Gimeno-Fabra M, Munn AS, Stevens LA, Drage TC, Grant DM, Kashtiban RJ, Sloan J, Lester E, Walton RI.

Chem Commun (Camb). 2012 Nov 7;48(86):10642-4. doi: 10.1039/c2cc34493a.

PMID:
23000779
22.

Impact of water coadsorption for carbon dioxide capture in microporous polymer sorbents.

Dawson R, Stevens LA, Drage TC, Snape CE, Smith MW, Adams DJ, Cooper AI.

J Am Chem Soc. 2012 Jul 4;134(26):10741-4. doi: 10.1021/ja301926h. Epub 2012 Jun 20.

PMID:
22687058
23.

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).

Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA, Norris KC, Whaley-Connell AT, Bakris GL, McCullough PA.

Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S9-16. doi: 10.1053/j.ajkd.2010.11.007.

24.

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP).

McFarlane SI, McCullough PA, Sowers JR, Soe K, Chen SC, Li S, Vassalotti JA, Stevens LA, Salifu MO, Kurella Tamura M, Bomback AS, Norris KC, Collins AJ, Bakris GL, Whaley-Connell AT; KEEP Steering Committee.

Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S24-31. doi: 10.1053/j.ajkd.2010.11.009.

25.

Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations.

Kurella Tamura M, Anand S, Li S, Chen SC, Whaley-Connell AT, Stevens LA, Norris KC.

Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S17-23. doi: 10.1053/j.ajkd.2010.11.008.

26.

Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system).

Klonoff DC, Zimliki CL, Stevens LA, Beaston P, Pinkos A, Choe SY, Arreaza-Rubín G, Heetderks W.

J Diabetes Sci Technol. 2011 May 1;5(3):804-26.

27.

Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease.

Tent H, Waanders F, Krikken JA, Heerspink HJ, Stevens LA, Laverman GD, Navis G.

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii89-95. doi: 10.1093/ndt/gfr235. Epub 2011 May 11.

PMID:
21562145
28.

A predictive model for progression of chronic kidney disease to kidney failure.

Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS.

JAMA. 2011 Apr 20;305(15):1553-9. doi: 10.1001/jama.2011.451. Epub 2011 Apr 11.

PMID:
21482743
29.

Responding to the difficult patient.

Stevens LA.

Bull Am Coll Surg. 2010 May;95(5):12-5. No abstract available.

PMID:
21452641
30.

Timing hemodialysis initiation: a call for clinical judgment.

Weiner DE, Stevens LA.

Am J Kidney Dis. 2011 Apr;57(4):562-5. doi: 10.1053/j.ajkd.2011.01.003. Epub 2011 Feb 5. No abstract available.

PMID:
21295899
31.

mTOR inhibitors and autosomal dominant polycystic kidney disease.

Levey AS, Stevens LA.

N Engl J Med. 2011 Jan 20;364(3):287; author reply 287-9. doi: 10.1056/NEJMc1010845. No abstract available.

PMID:
21247327
32.

Classification of chronic kidney disease: a step forward.

Levey AS, Tangri N, Stevens LA.

Ann Intern Med. 2011 Jan 4;154(1):65-7. doi: 10.7326/0003-4819-154-1-201101040-00012. No abstract available.

PMID:
21200043
33.

Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.

Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS.

Kidney Int. 2011 Mar;79(5):555-62. doi: 10.1038/ki.2010.462. Epub 2010 Nov 24.

34.

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate.

Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, Coresh J, Levey AS.

Kidney Int. 2011 Feb;79(4):471-7. doi: 10.1038/ki.2010.431. Epub 2010 Oct 27.

35.

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS.

Clin J Am Soc Nephrol. 2011 Jan;6(1):184-91. doi: 10.2215/CJN.05030610. Epub 2010 Oct 21.

36.

Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset.

Stoycheff N, Pandya K, Okparavero A, Schiff A, Levey AS, Greene T, Stevens LA.

Nephrol Dial Transplant. 2011 Mar;26(3):848-57. doi: 10.1093/ndt/gfq525. Epub 2010 Sep 3. Review.

37.

Clinical impact of reporting estimated glomerular filtration rates.

Hostetter TH, Levey AS, Stevens LA.

Clin Chem. 2010 Sep;56(9):1381-3. doi: 10.1373/clinchem.2010.147827. Epub 2010 Jul 13. No abstract available.

38.

Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function.

Tent H, Rook M, Stevens LA, van Son WJ, van Pelt LJ, Hofker HS, Ploeg RJ, van der Heide JJ, Navis G.

Clin J Am Soc Nephrol. 2010 Nov;5(11):1960-8. doi: 10.2215/CJN.08761209. Epub 2010 Jul 8.

39.

Prevalence of and risk factors for chronic kidney disease in rural Nicaragua.

O'Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, Cohen B, Brooks DR.

Nephrol Dial Transplant. 2011 Sep;26(9):2798-805. doi: 10.1093/ndt/gfq385. Epub 2010 Jul 8.

40.

Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance.

Stevens LA, Viswanathan G, Weiner DE.

Adv Chronic Kidney Dis. 2010 Jul;17(4):293-301. doi: 10.1053/j.ackd.2010.03.010.

41.

Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.

Fanikos J, Stevens LA, Labreche M, Piazza G, Catapane E, Novack L, Goldhaber SZ.

Am J Med. 2010 Jun;123(6):536-41. doi: 10.1016/j.amjmed.2009.11.017.

PMID:
20569760
42.

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS.

Am J Kidney Dis. 2010 Sep;56(3):486-95. doi: 10.1053/j.ajkd.2010.03.026. Epub 2010 Jun 16.

43.

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Kwong YT, Stevens LA, Selvin E, Zhang YL, Greene T, Van Lente F, Levey AS, Coresh J.

Am J Kidney Dis. 2010 Jul;56(1):39-49. doi: 10.1053/j.ajkd.2010.02.347.

44.

Chronic kidney disease, diabetes, and hypertension: what's in a name?

Levey AS, Astor BC, Stevens LA, Coresh J.

Kidney Int. 2010 Jul;78(1):19-22. doi: 10.1038/ki.2010.115. Epub 2010 Apr 28. Review.

45.

Advances in glomerular filtration rate-estimating equations.

Stevens LA, Padala S, Levey AS.

Curr Opin Nephrol Hypertens. 2010 May;19(3):298-307. doi: 10.1097/MNH.0b013e32833893e2. Review.

46.
47.

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S23-33. doi: 10.1053/j.ajkd.2009.09.035.

48.

Multi-screen electronic alerts to augment venous thromboembolism prophylaxis.

Fiumara K, Piovella C, Hurwitz S, Piazza G, Niles CM, Fanikos J, Paterno M, Labreche M, Stevens LA, Baroletti S, Goldhaber SZ.

Thromb Haemost. 2010 Feb;103(2):312-7. doi: 10.1160/TH09-09-0634. Epub 2009 Nov 13.

PMID:
20126839
49.

Impact of reporting estimated glomerular filtration rate: it's not just about us.

Stevens LA, Levey AS.

Kidney Int. 2009 Aug;76(3):245-7. doi: 10.1038/ki.2009.143.

50.

ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine.

Stevens LA, Levine RL, Gochuico BR, Moss J.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19796-800. doi: 10.1073/pnas.0910633106. Epub 2009 Nov 6.

Supplemental Content

Loading ...
Support Center